Chronic Wounds

·MeSH: Bronchiolitis Obliterans Syndrome

8 drugs in development·6 companies·1 clinical trial

Drug Pipeline by Phase

Approved(8)

Drug	Company
altrazeal	ULURU INC. (ULU)
chitoskin	SANGUI BIOTECH INTERNATIONAL INC (SGBI)
EPIFIX	MiMedx Group Inc (MDXG)
grafix	OSIRIS THERAPEUTICS, INC. (OSIR)
granulox	SANGUI BIOTECH INTERNATIONAL INC (SGBI)
hemospray	SANGUI BIOTECH INTERNATIONAL INC (SGBI)
sofpulse	ENDONOVO THERAPEUTICS, INC. (ENDV)
xcellderma otc	REGENEREX PHARMA, INC. (RGPX)

BioSniper tracks 8 drugs in development for Chronic Wounds across 6 companies.

There are 1 clinical trial targeting Chronic Wounds tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.